Structure

Physi-Chem Properties

Molecular Weight:  374.08
Volume:  370.026
LogP:  4.596
LogD:  2.827
LogS:  -4.099
# Rotatable Bonds:  0
TPSA:  115.06
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.448
Synthetic Accessibility Score:  3.645
Fsp3:  0.091
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.476
MDCK Permeability:  1.278876698052045e-05
Pgp-inhibitor:  0.082
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.103
20% Bioavailability (F20%):  0.226
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  100.86504364013672%
Volume Distribution (VD):  0.348
Pgp-substrate:  1.4571999311447144%

ADMET: Metabolism

CYP1A2-inhibitor:  0.855
CYP1A2-substrate:  0.664
CYP2C19-inhibitor:  0.293
CYP2C19-substrate:  0.085
CYP2C9-inhibitor:  0.835
CYP2C9-substrate:  0.704
CYP2D6-inhibitor:  0.425
CYP2D6-substrate:  0.164
CYP3A4-inhibitor:  0.337
CYP3A4-substrate:  0.246

ADMET: Excretion

Clearance (CL):  3.208
Half-life (T1/2):  0.245

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.181
Drug-inuced Liver Injury (DILI):  0.963
AMES Toxicity:  0.849
Rat Oral Acute Toxicity:  0.441
Maximum Recommended Daily Dose:  0.767
Skin Sensitization:  0.828
Carcinogencity:  0.813
Eye Corrosion:  0.003
Eye Irritation:  0.507
Respiratory Toxicity:  0.151

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC193358

Natural Product ID:  NPC193358
Common Name*:   Zeylanone
IUPAC Name:   n.a.
Synonyms:   Zeylanone
Standard InCHIKey:  XVMQJJJRMHQCGD-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C22H14O6/c1-22-12(19(26)16-10(21(22)28)5-3-7-14(16)24)8-11-17(22)20(27)15-9(18(11)25)4-2-6-13(15)23/h2-7,12,23-24H,8H2,1H3
SMILES:  Oc1cccc2c1C(=O)C1=C(C2=O)CC2C1(C)C(=O)c1c(C2=O)c(O)ccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL470457
PubChem CID:   5276618
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000023] Naphthalenes
        • [CHEMONTID:0000153] Naphthoquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota bark Indonesia n.a. PMID[15270571]
NPO13608 Plumbago zeylanica Species Plumbaginaceae Eukaryota n.a. root n.a. PMID[16078700]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. PMID[22313254]
NPO13608 Plumbago zeylanica Species Plumbaginaceae Eukaryota n.a. n.a. n.a. PMID[23848163]
NPO13608 Plumbago zeylanica Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13608 Plumbago zeylanica Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13608 Plumbago zeylanica Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens ED50 = 2.1 ug ml-1 PMID[533037]
NPT1034 Cell Line Lu1 Homo sapiens ED50 = 14.5 ug ml-1 PMID[533037]
NPT858 Cell Line LNCaP Homo sapiens ED50 = 3.3 ug ml-1 PMID[533037]
NPT737 Cell Line HUVEC Homo sapiens ED50 = 3.3 ug ml-1 PMID[533037]
NPT729 Organism Micrococcus luteus Micrococcus luteus IC50 = 50.0 ug.mL-1 PMID[533037]
NPT729 Organism Micrococcus luteus Micrococcus luteus Activity > 800.0 ug ml-1 PMID[533037]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IC50 = 6.0 ug.mL-1 PMID[533037]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus Activity > 800.0 ug ml-1 PMID[533037]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis IC50 = 50.0 ug.mL-1 PMID[533037]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis Activity = 400.0 ug ml-1 PMID[533037]
NPT1513 Organism Mycobacterium avium Mycobacterium avium IC50 = 200.0 ug.mL-1 PMID[533037]
NPT1513 Organism Mycobacterium avium Mycobacterium avium Activity > 800.0 ug ml-1 PMID[533037]
NPT20 Organism Candida albicans Candida albicans IC50 = 3.0 ug.mL-1 PMID[533037]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans IC50 = 10.0 ug.mL-1 PMID[533037]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans Activity = 100.0 ug ml-1 PMID[533037]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae IC50 = 10.0 ug.mL-1 PMID[533037]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae Activity = 500.0 ug ml-1 PMID[533037]
NPT21 Organism Aspergillus niger Aspergillus niger IC50 = 30.0 ug.mL-1 PMID[533037]
NPT21 Organism Aspergillus niger Aspergillus niger Activity > 800.0 ug ml-1 PMID[533037]
NPT20 Organism Candida albicans Candida albicans Activity = 3.0 ug ml-1 PMID[533037]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC193358 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.903 High Similarity NPC53896
0.903 High Similarity NPC115458
0.9015 High Similarity NPC34414
0.9015 High Similarity NPC146647
0.8992 High Similarity NPC375356
0.8931 High Similarity NPC3224
0.8915 High Similarity NPC300274
0.8897 High Similarity NPC80035
0.8881 High Similarity NPC244699
0.8855 High Similarity NPC103540
0.8849 High Similarity NPC96421
0.8832 High Similarity NPC272268
0.8815 High Similarity NPC58685
0.8806 High Similarity NPC55949
0.8797 High Similarity NPC282923
0.8797 High Similarity NPC48248
0.8788 High Similarity NPC96915
0.8779 High Similarity NPC142956
0.8759 High Similarity NPC283088
0.875 High Similarity NPC225051
0.8731 High Similarity NPC99731
0.8731 High Similarity NPC25736
0.8722 High Similarity NPC471530
0.8705 High Similarity NPC13715
0.8686 High Similarity NPC50924
0.8682 High Similarity NPC206778
0.8682 High Similarity NPC285829
0.8667 High Similarity NPC475741
0.8647 High Similarity NPC306765
0.8626 High Similarity NPC307174
0.8603 High Similarity NPC17083
0.8603 High Similarity NPC205992
0.8571 High Similarity NPC4214
0.8561 High Similarity NPC474813
0.8561 High Similarity NPC472308
0.8561 High Similarity NPC155211
0.8551 High Similarity NPC288089
0.8529 High Similarity NPC199253
0.8529 High Similarity NPC136588
0.8511 High Similarity NPC26924
0.8507 High Similarity NPC474106
0.8507 High Similarity NPC231774
0.85 High Similarity NPC245923
0.85 High Similarity NPC36868
0.8496 Intermediate Similarity NPC173978
0.8496 Intermediate Similarity NPC310540
0.8462 Intermediate Similarity NPC193555
0.8451 Intermediate Similarity NPC315578
0.8429 Intermediate Similarity NPC474311
0.8417 Intermediate Similarity NPC472262
0.8417 Intermediate Similarity NPC161964
0.8417 Intermediate Similarity NPC287604
0.8406 Intermediate Similarity NPC70622
0.8394 Intermediate Similarity NPC31799
0.8392 Intermediate Similarity NPC91019
0.8392 Intermediate Similarity NPC477275
0.8392 Intermediate Similarity NPC106519
0.8372 Intermediate Similarity NPC108288
0.8369 Intermediate Similarity NPC305060
0.8369 Intermediate Similarity NPC118366
0.8358 Intermediate Similarity NPC234890
0.8358 Intermediate Similarity NPC74507
0.8346 Intermediate Similarity NPC91478
0.8345 Intermediate Similarity NPC52407
0.8345 Intermediate Similarity NPC79627
0.8345 Intermediate Similarity NPC294226
0.8333 Intermediate Similarity NPC474517
0.8333 Intermediate Similarity NPC72669
0.8322 Intermediate Similarity NPC181560
0.8322 Intermediate Similarity NPC169452
0.8321 Intermediate Similarity NPC276238
0.8309 Intermediate Similarity NPC84672
0.8309 Intermediate Similarity NPC69424
0.8309 Intermediate Similarity NPC72667
0.8309 Intermediate Similarity NPC176130
0.8309 Intermediate Similarity NPC78364
0.8298 Intermediate Similarity NPC141934
0.8286 Intermediate Similarity NPC12070
0.8286 Intermediate Similarity NPC44437
0.8276 Intermediate Similarity NPC66593
0.8273 Intermediate Similarity NPC246693
0.8273 Intermediate Similarity NPC110609
0.8273 Intermediate Similarity NPC242358
0.8271 Intermediate Similarity NPC120545
0.8261 Intermediate Similarity NPC108129
0.8252 Intermediate Similarity NPC138099
0.8252 Intermediate Similarity NPC1268
0.8252 Intermediate Similarity NPC242994
0.8248 Intermediate Similarity NPC96024
0.8248 Intermediate Similarity NPC237225
0.8239 Intermediate Similarity NPC475957
0.8239 Intermediate Similarity NPC53414
0.8239 Intermediate Similarity NPC471905
0.8239 Intermediate Similarity NPC53206
0.8235 Intermediate Similarity NPC71610
0.8235 Intermediate Similarity NPC254492
0.8231 Intermediate Similarity NPC477453
0.8231 Intermediate Similarity NPC143685
0.8227 Intermediate Similarity NPC258502
0.8227 Intermediate Similarity NPC249272
0.8214 Intermediate Similarity NPC171968
0.8214 Intermediate Similarity NPC477139
0.8214 Intermediate Similarity NPC114183
0.8207 Intermediate Similarity NPC19631
0.8207 Intermediate Similarity NPC239136
0.8207 Intermediate Similarity NPC69755
0.8194 Intermediate Similarity NPC225243
0.8188 Intermediate Similarity NPC171460
0.8182 Intermediate Similarity NPC477849
0.8182 Intermediate Similarity NPC91887
0.8182 Intermediate Similarity NPC46242
0.8182 Intermediate Similarity NPC473479
0.8182 Intermediate Similarity NPC51531
0.8182 Intermediate Similarity NPC157284
0.8182 Intermediate Similarity NPC5014
0.8182 Intermediate Similarity NPC165191
0.8182 Intermediate Similarity NPC297797
0.8182 Intermediate Similarity NPC28592
0.8182 Intermediate Similarity NPC61398
0.8182 Intermediate Similarity NPC114333
0.8182 Intermediate Similarity NPC289358
0.8182 Intermediate Similarity NPC473779
0.8182 Intermediate Similarity NPC42384
0.8182 Intermediate Similarity NPC232178
0.8182 Intermediate Similarity NPC416
0.8182 Intermediate Similarity NPC149773
0.8182 Intermediate Similarity NPC50615
0.8182 Intermediate Similarity NPC469857
0.8182 Intermediate Similarity NPC245760
0.8182 Intermediate Similarity NPC23667
0.8176 Intermediate Similarity NPC162751
0.8176 Intermediate Similarity NPC52161
0.8169 Intermediate Similarity NPC254847
0.8156 Intermediate Similarity NPC270899
0.8156 Intermediate Similarity NPC202225
0.8154 Intermediate Similarity NPC161304
0.8151 Intermediate Similarity NPC471682
0.8151 Intermediate Similarity NPC478164
0.8151 Intermediate Similarity NPC53016
0.8151 Intermediate Similarity NPC199936
0.8138 Intermediate Similarity NPC246638
0.8138 Intermediate Similarity NPC124365
0.8134 Intermediate Similarity NPC154696
0.8133 Intermediate Similarity NPC315520
0.8129 Intermediate Similarity NPC198305
0.8129 Intermediate Similarity NPC117609
0.8125 Intermediate Similarity NPC294330
0.8121 Intermediate Similarity NPC106524
0.8121 Intermediate Similarity NPC290695
0.812 Intermediate Similarity NPC318552
0.812 Intermediate Similarity NPC190501
0.8116 Intermediate Similarity NPC95537
0.8112 Intermediate Similarity NPC53001
0.8108 Intermediate Similarity NPC314437
0.8102 Intermediate Similarity NPC51037
0.8102 Intermediate Similarity NPC160499
0.8102 Intermediate Similarity NPC1991
0.8099 Intermediate Similarity NPC22222
0.8099 Intermediate Similarity NPC477596
0.8099 Intermediate Similarity NPC281513
0.8099 Intermediate Similarity NPC161632
0.8088 Intermediate Similarity NPC68756
0.8088 Intermediate Similarity NPC152525
0.8088 Intermediate Similarity NPC199273
0.8085 Intermediate Similarity NPC254603
0.8085 Intermediate Similarity NPC314048
0.8082 Intermediate Similarity NPC477209
0.8082 Intermediate Similarity NPC469520
0.8082 Intermediate Similarity NPC73061
0.8082 Intermediate Similarity NPC474300
0.8082 Intermediate Similarity NPC257644
0.8074 Intermediate Similarity NPC176208
0.8071 Intermediate Similarity NPC93015
0.8071 Intermediate Similarity NPC471851
0.8069 Intermediate Similarity NPC473527
0.806 Intermediate Similarity NPC259703
0.806 Intermediate Similarity NPC32322
0.8058 Intermediate Similarity NPC278928
0.8058 Intermediate Similarity NPC303910
0.8056 Intermediate Similarity NPC469680
0.8056 Intermediate Similarity NPC87723
0.8056 Intermediate Similarity NPC471974
0.8056 Intermediate Similarity NPC469681
0.8056 Intermediate Similarity NPC61590
0.8042 Intermediate Similarity NPC86524
0.8042 Intermediate Similarity NPC7464
0.8041 Intermediate Similarity NPC471683
0.8041 Intermediate Similarity NPC12402
0.8041 Intermediate Similarity NPC478160
0.8028 Intermediate Similarity NPC166480
0.8028 Intermediate Similarity NPC477594
0.8028 Intermediate Similarity NPC282780
0.8027 Intermediate Similarity NPC476473
0.8015 Intermediate Similarity NPC198014
0.8015 Intermediate Similarity NPC477153
0.8015 Intermediate Similarity NPC135062
0.8015 Intermediate Similarity NPC275145
0.8014 Intermediate Similarity NPC309430
0.8014 Intermediate Similarity NPC305845
0.8014 Intermediate Similarity NPC204045

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC193358 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8855 High Similarity NPD1470 Approved
0.855 High Similarity NPD1201 Approved
0.8372 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8169 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.812 Intermediate Similarity NPD3019 Approved
0.812 Intermediate Similarity NPD2932 Approved
0.7862 Intermediate Similarity NPD5404 Approved
0.7862 Intermediate Similarity NPD5405 Approved
0.7862 Intermediate Similarity NPD5406 Approved
0.7862 Intermediate Similarity NPD5408 Approved
0.7829 Intermediate Similarity NPD3226 Approved
0.7793 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD2346 Discontinued
0.7667 Intermediate Similarity NPD3300 Phase 2
0.7664 Intermediate Similarity NPD3026 Approved
0.7664 Intermediate Similarity NPD3023 Approved
0.7647 Intermediate Similarity NPD3025 Approved
0.7647 Intermediate Similarity NPD3024 Approved
0.7616 Intermediate Similarity NPD7390 Discontinued
0.7566 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7465 Intermediate Similarity NPD2798 Approved
0.7417 Intermediate Similarity NPD7003 Approved
0.7407 Intermediate Similarity NPD5951 Approved
0.7397 Intermediate Similarity NPD943 Approved
0.7394 Intermediate Similarity NPD1164 Approved
0.7379 Intermediate Similarity NPD3764 Approved
0.7338 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2344 Approved
0.7333 Intermediate Similarity NPD1471 Phase 3
0.7329 Intermediate Similarity NPD6663 Approved
0.7324 Intermediate Similarity NPD1876 Approved
0.7315 Intermediate Similarity NPD2799 Discontinued
0.7303 Intermediate Similarity NPD8166 Discontinued
0.7292 Intermediate Similarity NPD5736 Approved
0.729 Intermediate Similarity NPD6273 Approved
0.7267 Intermediate Similarity NPD2935 Discontinued
0.7266 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD2313 Discontinued
0.725 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD4059 Approved
0.7194 Intermediate Similarity NPD3091 Approved
0.7183 Intermediate Similarity NPD4878 Approved
0.7143 Intermediate Similarity NPD2342 Discontinued
0.7143 Intermediate Similarity NPD2309 Approved
0.7122 Intermediate Similarity NPD7610 Discontinued
0.709 Intermediate Similarity NPD9266 Approved
0.709 Intermediate Similarity NPD74 Approved
0.7086 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD3750 Approved
0.7066 Intermediate Similarity NPD7473 Discontinued
0.705 Intermediate Similarity NPD9493 Approved
0.7044 Intermediate Similarity NPD7458 Discontinued
0.7044 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD9263 Approved
0.7015 Intermediate Similarity NPD9264 Approved
0.7015 Intermediate Similarity NPD9267 Approved
0.7007 Intermediate Similarity NPD7635 Approved
0.6993 Remote Similarity NPD3092 Approved
0.6988 Remote Similarity NPD6232 Discontinued
0.6974 Remote Similarity NPD1510 Phase 2
0.6972 Remote Similarity NPD3095 Discontinued
0.6972 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6963 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6959 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6954 Remote Similarity NPD1607 Approved
0.6951 Remote Similarity NPD3749 Approved
0.695 Remote Similarity NPD7009 Phase 2
0.6933 Remote Similarity NPD1240 Approved
0.6918 Remote Similarity NPD3094 Phase 2
0.6918 Remote Similarity NPD1203 Approved
0.6913 Remote Similarity NPD3268 Approved
0.6903 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6899 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6883 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6879 Remote Similarity NPD7236 Approved
0.6875 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6871 Remote Similarity NPD7819 Suspended
0.6867 Remote Similarity NPD8032 Phase 2
0.6859 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6857 Remote Similarity NPD8150 Discontinued
0.6852 Remote Similarity NPD7411 Suspended
0.6849 Remote Similarity NPD1283 Approved
0.6846 Remote Similarity NPD288 Approved
0.6846 Remote Similarity NPD7008 Discontinued
0.6842 Remote Similarity NPD1930 Approved
0.6842 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6842 Remote Similarity NPD1929 Approved
0.6839 Remote Similarity NPD970 Clinical (unspecified phase)
0.6828 Remote Similarity NPD3972 Approved
0.6826 Remote Similarity NPD6959 Discontinued
0.6818 Remote Similarity NPD289 Clinical (unspecified phase)
0.6815 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6806 Remote Similarity NPD4879 Approved
0.6795 Remote Similarity NPD2800 Approved
0.6792 Remote Similarity NPD4378 Clinical (unspecified phase)
0.679 Remote Similarity NPD7028 Phase 2
0.6786 Remote Similarity NPD9281 Approved
0.6782 Remote Similarity NPD8313 Approved
0.6782 Remote Similarity NPD8312 Approved
0.6763 Remote Similarity NPD5027 Approved
0.6763 Remote Similarity NPD5029 Approved
0.6763 Remote Similarity NPD5031 Approved
0.6755 Remote Similarity NPD7961 Discontinued
0.6753 Remote Similarity NPD3748 Approved
0.6753 Remote Similarity NPD4308 Phase 3
0.6752 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6742 Remote Similarity NPD3020 Approved
0.6731 Remote Similarity NPD1549 Phase 2
0.6724 Remote Similarity NPD4954 Approved
0.6724 Remote Similarity NPD5028 Approved
0.6724 Remote Similarity NPD4955 Approved
0.6724 Remote Similarity NPD36 Approved
0.6724 Remote Similarity NPD5026 Approved
0.6724 Remote Similarity NPD5034 Approved
0.6716 Remote Similarity NPD9261 Approved
0.6712 Remote Similarity NPD9717 Approved
0.671 Remote Similarity NPD6099 Approved
0.671 Remote Similarity NPD6100 Approved
0.6706 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6691 Remote Similarity NPD1609 Clinical (unspecified phase)
0.669 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6689 Remote Similarity NPD3266 Approved
0.6689 Remote Similarity NPD3267 Approved
0.6689 Remote Similarity NPD411 Approved
0.6689 Remote Similarity NPD2797 Approved
0.6687 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6687 Remote Similarity NPD4380 Phase 2
0.6687 Remote Similarity NPD2534 Approved
0.6687 Remote Similarity NPD2532 Approved
0.6687 Remote Similarity NPD2533 Approved
0.6687 Remote Similarity NPD7768 Phase 2
0.6685 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5030 Phase 2
0.6667 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6667 Remote Similarity NPD447 Suspended
0.6667 Remote Similarity NPD5033 Approved
0.6667 Remote Similarity NPD3021 Approved
0.6667 Remote Similarity NPD1651 Approved
0.6667 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1237 Approved
0.6667 Remote Similarity NPD1755 Approved
0.6667 Remote Similarity NPD7239 Suspended
0.6667 Remote Similarity NPD4750 Phase 3
0.6667 Remote Similarity NPD3022 Approved
0.6644 Remote Similarity NPD4624 Approved
0.6644 Remote Similarity NPD1281 Approved
0.6642 Remote Similarity NPD1932 Approved
0.6641 Remote Similarity NPD844 Approved
0.6627 Remote Similarity NPD2296 Approved
0.6625 Remote Similarity NPD1511 Approved
0.6619 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6611 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6606 Remote Similarity NPD6844 Discontinued
0.6606 Remote Similarity NPD1934 Approved
0.6603 Remote Similarity NPD1551 Phase 2
0.6594 Remote Similarity NPD2329 Discontinued
0.6592 Remote Similarity NPD6836 Approved
0.6591 Remote Similarity NPD3495 Discontinued
0.6587 Remote Similarity NPD3882 Suspended
0.6573 Remote Similarity NPD5037 Approved
0.6573 Remote Similarity NPD5038 Approved
0.6573 Remote Similarity NPD8434 Phase 2
0.6568 Remote Similarity NPD5494 Approved
0.6566 Remote Similarity NPD2801 Approved
0.6566 Remote Similarity NPD5761 Phase 2
0.6566 Remote Similarity NPD5760 Phase 2
0.6558 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6556 Remote Similarity NPD6832 Phase 2
0.6554 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6552 Remote Similarity NPD4093 Discontinued
0.6552 Remote Similarity NPD4956 Approved
0.6543 Remote Similarity NPD1512 Approved
0.6541 Remote Similarity NPD4628 Phase 3
0.6534 Remote Similarity NPD5032 Approved
0.6529 Remote Similarity NPD8127 Discontinued
0.6527 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6522 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6517 Remote Similarity NPD5036 Approved
0.6516 Remote Similarity NPD6651 Approved
0.6516 Remote Similarity NPD4097 Suspended
0.6515 Remote Similarity NPD2860 Approved
0.6515 Remote Similarity NPD2859 Approved
0.6513 Remote Similarity NPD5156 Approved
0.6513 Remote Similarity NPD5155 Approved
0.6507 Remote Similarity NPD2286 Discontinued
0.6507 Remote Similarity NPD4626 Approved
0.6497 Remote Similarity NPD5035 Approved
0.6497 Remote Similarity NPD2796 Approved
0.6494 Remote Similarity NPD4140 Approved
0.6494 Remote Similarity NPD6020 Phase 2
0.6494 Remote Similarity NPD4307 Phase 2
0.6493 Remote Similarity NPD2066 Phase 3
0.6489 Remote Similarity NPD845 Approved
0.6486 Remote Similarity NPD1608 Approved
0.6485 Remote Similarity NPD6599 Discontinued
0.6484 Remote Similarity NPD6212 Phase 3
0.6484 Remote Similarity NPD6213 Phase 3
0.6484 Remote Similarity NPD6214 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data